NCT06795022
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06795022
Title First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours (RHEA-1)
Acronym RHEA-1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Research Site WITHDRAWN La Jolla California 92093 United States Details
Research Site RECRUITING Los Angeles California 90089 United States Details
Research Site NOT_YET_RECRUITING Baltimore Maryland 21201 United States Details
Research Site NOT_YET_RECRUITING Boston Massachusetts 02114 United States Details
Research Site RECRUITING St Louis Missouri 63108 United States Details
Research Site RECRUITING Hackensack New Jersey 07601 United States Details
Research Site RECRUITING Houston Texas 77030 United States Details
Research Site RECRUITING Chengdu 610041 China Details
Research Site RECRUITING Guangzhou 510515 China Details
Research Site NOT_YET_RECRUITING Harbin 150049 China Details
Research Site RECRUITING Shanghai 201114 China Details
Research Site RECRUITING Pokfulam 999077 Hong Kong Details
Research Site RECRUITING Shatin 000000 Hong Kong Details
Research Site RECRUITING Kashiwa 277-8577 Japan Details
Research Site RECRUITING Yokohama 241-8515 Japan Details
Research Site NOT_YET_RECRUITING Seoul 06351 South Korea Details
Research Site RECRUITING Seoul 5505 South Korea Details
Research Site NOT_YET_RECRUITING Barcelona 8035 Spain Details
Research Site NOT_YET_RECRUITING Pamplona 31005 Spain Details
Research Site RECRUITING Taipei 10002 Taiwan Details
Research Site RECRUITING Taoyuan 333 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field